Drug intelligence / Profile preview

ferrous ascorbate + folic acid + zinc sulfate

Development stage
Unknown
Lead developer
Allgems Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Gemofer is an oral hematinic supplement developed and marketed by Allgems Healthcare, primarily indicated for the treatment and prevention of iron deficiency anemia. It is a combination product typically composed of ferrous ascorbate, folic acid (Vitamin B9), and zinc sulfate. Ferrous ascorbate is a synthetic chelate of ferrous iron and ascorbic acid that provides high elemental iron bioavailability with improved gastrointestinal tolerance compared to traditional iron salts. Folic acid is essential for DNA synthesis and the maturation of red blood cells, helping to prevent megaloblastic anemia. Zinc sulfate acts as a cofactor for numerous enzymes involved in cellular metabolism and immune function. Gemofer is commonly used to manage nutritional deficiencies, anemia during pregnancy and lactation, and recovery from chronic blood loss.

Brand names
Gemofer
02

Targets

DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on ferrous ascorbate + folic acid + zinc sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ferrous ascorbate + folic acid + zinc sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call